Aromatase inhibition for breast cancer treatment
Open accessAbstract
While the first generation aromatase inhibitor aminoglutethimide and second- and third generation inhibitors like formestane and fadrozole all have been found to inhibit in vivo aromatization by 85-93%, the novel aromatase inhibitors letrozole and arimidex inhibit in vivo aromatization by 97-99%. However, we do not know whether these drugs cause a higher response rate or a longer duration of remission compared with less potent aromatase inhibitors. Lack of cross-resistance to steroidal and non-steroidal aromatase inhibitors suggests that these drugs may have partially different mechanisms of action, probably by influencing the intratumour aromatase enzyme. Recent studies have shown that breast cancer cells may adapt to alterations in oestrogen concentration in vitro by increasing their sensitivity. The observation that patients suffering relapse following castration, hypophysectomy or adrenalectomy may respond to treatment with aromatase inhibitors suggests that similar mechanisms could be responsible for acquired resistance to oestrogen deprivation.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Aromatase catalyzes the rate-limiting final step in estrogen production, the hydroxylation of androstenedione to estrone and of T to E2.
“It catalyzes the rate-limiting final step in estrogen (E) production, the hydroxylation of androstenedione to estrone and of T to E 2 (Fig. 1).”
From A new era in ovulation induction (2006) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay.
Klein, K. O., Baron, J., Colli, M. J., McDonnell, D. P., & Cutler, G. B. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117616 · Cited by 376 · see citing works
Santen, R. J., Santner, S. J., DAVIS, B., Veldhuis, J. D., SAMOJLIK, E., & Ruby, E. B. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-47-6-1257 · Cited by 342 · see citing works
Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells
Masamura, S., Santner, S. J., Heitjan, D. F., & Santen, R. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.10.7559875 · Cited by 307 · see citing works
Dowsett, M., Jones, A. L., Johnston, S. R. D., Jacobs, S., Trunet, P. F., & Smith, I. E. (1995) · PubMed · Cited by 238 · see citing works
Estrogen formation in stromal cells of adipose tissue of women: induction by glucocorticosteroids.
Simpson, E. R., Ackerman, G. E., Smith, M. E., & Mendelson, C. R. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5690 · Cited by 175 · see citing works
Control of aromatase activity in breast cancer cells: The role of cytokines and growth factors
Reed, M. J., Topping, L., Coldham, N. G., Purohit, A., Ghilchik, M. W., & James, V. H. T. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90264-w · Cited by 111 · see citing works
Lønning, P. E., Dowsett, M., & Powles, T. (1990) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(90)90241-j · Cited by 103 · see citing works
Mechanisms of Action of Aminoglutethimide as Endocrine Therapy of Breast Cancer
Lønning, P. E., & Kvinnsland, S. (1988) · Drugs · doi:10.2165/00003495-198835060-00005 · Cited by 102 · see citing works
Demers, L. M. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00682744 · Cited by 95 · see citing works
SAMOJLIK, E., Santen, R. J., & Wells, S. A. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-3-480 · Cited by 95 · see citing works
MacNeill, F., Jones, A. L., Jacobs, S., Lønning, P. E., Powles, T., & Dowsett, M. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.339 · Cited by 91 · see citing works
Jones, A., MacNeill, F., Jacobs, S., et al. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90074-c · Cited by 88 · see citing works
Dowsett, M., Stein, R. C., & Coombes, R. C. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90201-s · Cited by 81 · see citing works
Murray, R., & Pitt, P. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00665976 · Cited by 80 · see citing works
Lønning, P. E., Johannessen, D. C., & Thorsen, T. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.231 · Cited by 60 · see citing works
Analysis of the aromatase cytochrome P450 gene in human breast cancers
Sourdaine, P., Parker, M. G., Telford, J., & Miller, W. R. (1994) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0130331 · Cited by 58 · see citing works
Kadohama, N., Yarborough, C., Zhou, D., Chen, S., & Osawa, Y. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90295-t · Cited by 55 · see citing works
Klein, K. O., Demers, L. M., Santner, S. J., Baron, J., Cutler, G. B., & Santen, R. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7673408 · Cited by 54 · see citing works
Geisler, J., Johannessen, D. C., Anker, G. B., & Lønning, P. E. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00623-0 · Cited by 52 · see citing works
Lønning, P. E., & Ekse, D. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00180-8 · Cited by 51 · see citing works
Jacobs, S., Lønning, P. E., Haynes, B. P., Griggs, L., & Dowsett, M. (1991) · Journal of enzyme inhibition · doi:10.3109/14756369109030396 · Cited by 44 · see citing works
Lønning, P. E., Dowsett, M., Jones, A. L., Ekse, D., Jacobs, S., McNeil, F., Johannessen, D. C., & Powles, T. J. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01831476 · Cited by 29 · see citing works
Aminoglutethimide enzyme induction: pharmacological and endocrinological implications
Lønning, P. E. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf02897223 · Cited by 27 · see citing works
MacNeill, F., Jacobs, S., Lønning, P. E., et al. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.230 · Cited by 27 · see citing works
SAMOJLIK, E., Santen, R. J., & Worgul, T. J. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb00058.x · Cited by 26 · see citing works
Treatment of breast cancer with aromatase inhibitors – current status and future prospects
Lønning, P. E., Dowsett, M., & Powles, T. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.208 · Cited by 17 · see citing works
New Endocrine Drugs for Treatment of Advanced Breast Cancer
Lønning, P. E. (1990) · Acta Oncologica · doi:10.3109/02841869009090018 · Cited by 12 · see citing works
Beneficial response to pituitary ablation following aminoglutethimide
Bundred, N. J., Eremin, O., Stewart, H. J. S., et al. (1986) · British journal of surgery · doi:10.1002/bjs.1800730525 · Cited by 11 · see citing works
Geisler, J., Lønning, P. E., Dowsett, M., et al. (1995) · The Breast · doi:10.1016/0960-9776(95)90094-2 · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Samojlik E. Santen RJ, Wells SA. Adrenal suppression with aminoglutethimide. 11. Differential effects of aminog- lutethimide on plasma androstenedione and oestrogen levels. J Clin Endocrinol Metab 1977; 45: 480-487.
Cited by
Sorted by citations
Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu042 · Cited by 1,165 · see citing works
A new era in ovulation induction
Holzer, H., Casper, R., & Tulandi, T. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.05.078 · Cited by 194 · see citing works
Letrozole: A Review of its Use in Postmenopausal Women with Advanced Breast Cancer
Lamb, H. M., & Adkins, J. C. (1998) · Drugs · doi:10.2165/00003495-199856060-00020 · Cited by 109 · see citing works
- Authors
- Loünning, P. E.
- Venue
- Acta Oncologica
- Published
- 1996-01
- Volume
- 35
- Issue
- sup5
- Pages
- 38-43
- ISSN
- 0284-186X (ISSN-L)
- 1651-226X
- OpenAlex
- W2008709302
- Cited by
- 39
- References
- 29
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 1 · 2020: 1 · 2016: 1 · 2014: 1
- FWCI
- 0.51
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Acta Oncologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Advanced Breast Cancer Therapies
- Keywords
- aromatase inhibitors, breast cancer, letrozole, anastrozole, aminoglutethimide, formestane, fadrozole, estrogen deprivation, acquired resistance, oestrogen receptor, treatment response
- MeSH terms
- Antineoplastic Agents, Aromatase, Breast Neoplasms, Enzyme Inhibitors, Humans, Neoplasms, Hormone-Dependent, Drug Resistance, Neoplasm, Aromatase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
